8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

1/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

2/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

3/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

4/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

5/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

6/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

7/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

8/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

9/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

10/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

11/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

12/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

13/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

14/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

15/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

16/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

17/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

18/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

19/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

20/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

21/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

22/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

23/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

24/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

25/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

26/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

27/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

28/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

29/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

30/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

31/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

32/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

33/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

34/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

35/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

36/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

37/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

38/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

39/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

40/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

41/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

42/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

43/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

44/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

45/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

46/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

47/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

48/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

49/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

50/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

51/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

52/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

53/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

54/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

55/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

56/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

57/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

58/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

59/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

60/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

61/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

62/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

63/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

64/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

65/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

66/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

67/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

68/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

69/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

70/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

71/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

72/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

73/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

74/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

75/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

76/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

77/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

78/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

79/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

80/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

81/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

82/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

83/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

84/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

85/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

86/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

87/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

88/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

89/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

90/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

91/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

92/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

93/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

94/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

95/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

96/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

97/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

98/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

99/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

100/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

101/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

102/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

103/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

104/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

105/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

106/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

107/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

108/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

109/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

110/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

111/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

112/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

113/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

114/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

115/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

116/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

117/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

118/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

119/120

8/11/2019 Report on the Risk Assessment of Ketamine in the Framework of the Joint Action on New Synthetic Drugs

120/120